Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: BOLDER BIOTECHNOLOGY INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2021-08-23 to 2022-03-22
Current total value of award: $249876.75
Description: NO-COST EXTENSION TO THE AWARD OF BOLDER'S DHA SBIR PHASE I MEDICAL R&D PURCHASE ORDER FOR "EVALUATING BBT-059 AS A MEDICAL COUNTERMEASURE TO PROTECT AGAINST HEMATOPOIETIC ACUTE RADIATION SYNDROME